Pierre Vandepapelière

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

Lawrence R. Stanberry, Spotswood L. Spruance, Anthony L. Cunningham et al. · New England Journal of Medicine · 2002 · 788 citations

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Pierre Vandepapelière, Yves Horsmans, Philippe Moris et al. · Vaccine · 2008 · 220 citations

Vaccination, Healthy Adult Volunteers, Vaccine Development +12

Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine

Pierre Vandepapelière, George Lau, Geert Leroux‐Roels et al. · Vaccine · 2007 · 175 citations

Vaccination, Hepatitis D, Virus Suppression +10

Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid

Bernard Lauwerys, É. Hachulla, François Spertini et al. · Arthritis & Rheumatism · 2012 · 166 citations

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

S Thoelen, Pierre Van Damme, Catharina Matheï et al. · Vaccine · 1998 · 157 citations

Vaccination, Viral Hepatitis, Novel Adjuvant System +9